Antonio Cortés

发表

Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area

J. Mallol, C. Lluis, S. Ferré, 2017, The Journal of Neuroscience.

Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease

M. Scarselli, C. Lluis, S. Ferré, 2019, bioRxiv.

Heptaspanning membrane receptors and cytoskeletal/scaffolding proteins

F. Ciruela, J. Mallol, C. Lluis, 2007, Journal of Molecular Neuroscience.

Heteroreceptor Complexes Formed by Dopamine D1, Histamine H3, and N-Methyl-D-Aspartate Glutamate Receptors as Targets to Prevent Neuronal Death in Alzheimer’s Disease

Gemma Navarro, Rafael Franco, Peter J. McCormick, 2017, Molecular Neurobiology.

Moonlighting Adenosine Deaminase: A Target Protein for Drug Development

J. Mallol, C. Lluis, V. Casadó, 2015, Medicinal research reviews.

Targeting the dopamine D3 receptor: an overview of drug design strategies

V. Casadó, A. Cortés, E. Moreno, 2016, Expert opinion on drug discovery.

α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands

J. Meiler, S. Ferré, V. Casadó, 2018, Molecular Neurobiology.

Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia

J. Lanciego, J. Mallol, C. Lluis, 2015, Molecular Neurobiology.

Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain*

J. Lanciego, J. Mallol, C. Lluis, 2012, The Journal of Biological Chemistry.

Cocaine Disrupts Histamine H3 Receptor Modulation of Dopamine D1 Receptor Signaling: σ1-D1-H3 Receptor Complexes as Key Targets for Reducing Cocaine's Effects

J. Mallol, C. Lluis, S. Ferré, 2014, The Journal of Neuroscience.

Basic Concepts in G-Protein-Coupled Receptor Homo- and Heterodimerization

J. Mallol, C. Lluis, R. Franco, 2007, TheScientificWorldJournal.

Orexin–Corticotropin-Releasing Factor Receptor Heteromers in the Ventral Tegmental Area as Targets for Cocaine

J. Mallol, C. Lluis, S. Ferré, 2015, The Journal of Neuroscience.

Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors

Rob Leurs, Sergi Ferré, Rafael Franco, 2009, British journal of pharmacology.

Jordi Ortiz, Sergi Ferré, Rafael Franco, 2012, PLoS biology.

Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins

J. Mallol, C. Lluis, V. Casadó, 2018, Front. Pharmacol..

Homodimerization of adenosine A1 receptors in brain cortex explains the biphasic effects of caffeine

J. Mallol, C. Lluis, V. Casadó, 2013, Neuropharmacology.

Human adenosine deaminase as an allosteric modulator of human A1 adenosine receptor: abolishment of negative cooperativity for [3H](R)‐pia binding to the caudate nucleus

J. Mallol, C. Lluis, R. Franco, 2008, Journal of neurochemistry.

Chapter 74 – Caffeine, Adenosine A1 Receptors, and Brain Cortex. Molecular Aspects

V. Casadó, E. Moreno, Verònica Casadó-Anguera, 2016 .

Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1–A2A Receptor Heteromers

Graeme Milligan, Francisco Ciruela, Meritxell Canals, 2006, The Journal of Neuroscience.

Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs

V. Casadó, E. Moreno, Verònica Casadó-Anguera, 2019, Expert opinion on drug discovery.

Reinterpreting anomalous competitive binding experiments within G protein‐coupled receptor homodimers using a dimer receptor model

J. Mallol, S. Ferré, V. Casadó, 2019, Pharmacological research.

G protein-coupled receptor heteromers as new targets for drug development.

Gemma Navarro, Sergi Ferré, Rafael Franco, 2010, Progress in molecular biology and translational science.

Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers.

C. Lluis, R. Franco, F. Albericio, 2009, Journal of medicinal chemistry.

Interactions between Intracellular Domains as Key Determinants of the Quaternary Structure and Function of Receptor Heteromers*

L. Pardo, J. Mallol, C. Lluis, 2010, The Journal of Biological Chemistry.

Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain

L. Pardo, J. Mallol, C. Lluis, 2018, BMC Biology.

Detection of heteromerization of more than two proteins by sequential BRET-FRET

Gemma Navarro, Francisco Ciruela, Sergi Ferré, 2008, Nature Methods.

Cellular / Molecular Cocaine Disrupts Histamine H 3 Receptor Modulation of Dopamine D 1 Receptor Signaling : 1-D 1H 3 Receptor Complexes as Key Targets for Reducing Cocaine ’ s Effects

J. Mallol, C. Lluis, S. Ferré, 2014 .

The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome.

V. Casadó, A. Cortés, E. Moreno, 2019, Advances in pharmacology.

G‐protein‐coupled receptor heteromers: function and ligand pharmacology

J. Mallol, C. Lluis, E. Canela, 2008, British journal of pharmacology.

Identification of Dopamine D1–D3 Receptor Heteromers

K. Fuxe, D. Marcellino, H. Stark, 2008, Journal of Biological Chemistry.

IDENTIFICATION OF DOPAMINE D 1 -D 3 RECEPTOR HETEROMERS: INDICATIONS FOR A ROLE OF SYNERGISTIC D 1 -D 3 RECEPTOR INTERACTIONS IN THE STRIATUM*

K. Fuxe, D. Marcellino, H. Stark, 2008 .

Novel pharmacological targets based on receptor heteromers

J. Mallol, C. Lluis, R. Franco, 2008, Brain Research Reviews.

Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens

S. Ferré, V. Casadó, X. Guitart, 2019, Molecular Neurobiology.

A solid-phase combinatorial approach for indoloquinolizidine-peptides with high affinity at D(1) and D(2) dopamine receptors.

L. Pardo, C. Lluis, F. Albericio, 2015, European journal of medicinal chemistry.

Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index.

F. Ciruela, J. Mallol, C. Lluis, 2007, Pharmacology & therapeutics.

Dimer-based model for heptaspanning membrane receptors.

K. Fuxe, F. Ciruela, J. Mallol, 2005, Trends in biochemical sciences.

Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1–A2A Receptor Heteromers

F. Ciruela, R. Cunha, R. Luján, 2006, The Journal of Neuroscience.

Heterodimeric adenosine receptors: a device to regulate neurotransmitter release

F. Ciruela, R. Cunha, C. Lluis, 2006, Cellular and Molecular Life Sciences CMLS.

Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer.

L. Pardo, S. Ferré, V. Casadó, 2018, Journal of medicinal chemistry.

Striatal Pre- and Postsynaptic Profile of Adenosine A2A Receptor Antagonists

C. Lluis, R. Franco, S. Goldberg, 2011, PloS one.

The Two-State Dimer Receptor Model: A General Model for Receptor Dimers

K. Fuxe, F. Ciruela, J. Mallol, 2006, Molecular Pharmacology.

Evidence for the heterotetrameric structure of the adenosine A2A-dopamine D2 receptor complex.

S. Ferré, V. Casadó, Gemma Navarro, 2016, Biochemical Society transactions.

Biotin ergopeptide probes for dopamine receptors.

C. Lluis, R. Franco, F. Albericio, 2011, Journal of medicinal chemistry.

Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers

J. Mallol, C. Lluis, R. Franco, 2013, PloS one.

Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine

K. Fuxe, D. Marcellino, J. Mallol, 2010, Proceedings of the National Academy of Sciences.

The catalytic site structural gate of adenosine deaminase allosterically modulates ligand binding to adenosine receptors

M. Orozco, J. Mallol, C. Lluis, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer

N. Volkow, S. Schiffmann, J. Mallol, 2015, Proceedings of the National Academy of Sciences.

Heteromerization between α2A adrenoceptors and different polymorphic variants of the dopamine D4 receptor determines pharmacological and functional differences. Implications for impulsive-control disorders.

M. Rubinstein, S. Ferré, V. Casadó, 2021, Pharmacological research.

Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase

L. Pardo, C. Dessauer, C. Lluis, 2018, Nature Communications.

A Significant Role of the Truncated Ghrelin Receptor GHS-R1b in Ghrelin-induced Signaling in Neurons*

J. Mallol, C. Lluis, S. Ferré, 2016, The Journal of Biological Chemistry.

Functional role of the truncated ghrelin receptor 1 Significant Role of the Truncated Ghrelin Receptor GHS-R 1 b in Ghrelin-Induced Signaling in Neurons

J. Mallol, C. Lluis, S. Ferré, 2016 .

Adenosine A2A Receptors and A2A Receptor Heteromers as Key Players in Striatal Function

C. Lluis, R. Franco, S. Ferré, 2011, Front. Neuroanat..

Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans

C. Lluis, Z. Justinova, S. Ferré, 2013, Neuropharmacology.

Dopamine D1-histamine H3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway*

R. Moratalla, M. Vignes, J. Mallol, 2010, The Journal of Biological Chemistry.

Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function

R. Leurs, C. Lluis, R. Franco, 2008, Neuropharmacology.

A Hybrid Indoloquinolizidine Peptide as Allosteric Modulator of Dopamine D1 Receptors

J. Mallol, C. Lluis, R. Franco, 2010, Journal of Pharmacology and Experimental Therapeutics.

STRIATUM RECEPTOR INTERACTIONS IN THE D3 - FOR A ROLE OF SYNERGISTIC D1 Receptor Heteromers: INDICATIONS 3 D - 1 Identification of Dopamine D Mechanisms of Signal Transduction:

K. Fuxe, D. Marcellino, H. Stark, 2014 .

FOR A ROLE OF SYNERGISTIC D 1 Receptor Heteromers : INDICATIONS 3 D − 1 Identification of Dopamine D Mechanisms of Signal Transduction :

K. Fuxe, D. Marcellino, H. Stark, 2008 .

Interactions between Calmodulin, Adenosine A2A, and Dopamine D2 Receptors*

K. Fuxe, D. Marcellino, L. Agnati, 2009, The Journal of Biological Chemistry.

l-DOPA-treatment in primates disrupts the expression of A2A adenosine–CB1 cannabinoid–D2 dopamine receptor heteromers in the caudate nucleus

J. Lanciego, N. Luquin, C. Müller, 2014, Neuropharmacology.